All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
| NEWR / New Relic Inc
|
|
|
|
|
|
|
|
| HLTH / Cue Health Inc.
|
|
|
|
|
|
|
|
| PATH / UiPath Inc.
|
|
|
|
|
|
|
|
| S / SentinelOne, Inc.
|
|
|
|
|
|
|
|
| WE / WeWork Inc - Class A
|
|
|
|
|
|
|
|
| US29335V1061 / Enjoy Technology, Inc.
|
|
|
|
|
|
|
|
| IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
| GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| TOST / Toast, Inc.
|
|
|
|
|
|
|
|
| TCRX / TScan Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
| OMIC / Singular Genomics Systems, Inc.
|
|
|
|
|
|
|
|
| RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FRSH / Freshworks Inc.
|
|
|
|
|
|
|
|
| BHIL / Benson Hill, Inc.
|
|
|
|
|
|
|
|
| AMPL / Amplitude, Inc.
|
|
|
|
|
|
|
|
| IVVD / Invivyd, Inc.
|
|
|
|
|
|
|
|
| HOOD / Robinhood Markets, Inc.
|
|
|
|
|
|
|
|
| MGTA / Magenta Therapeutics Inc
|
|
|
|
|
|
|
|
| BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
| FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
| LYFT / Lyft, Inc.
|
|
|
|
|
|
|
|
| DBTX / Decibel Therapeutics Inc
|
|
|
|
|
|
|
|
| OPRT / Oportun Financial Corporation
|
|
|
|
|
|
|
|
| OSCR / Oscar Health, Inc.
|
|
|
|
|
|
|
|
| VLD / Velo3D, Inc.
|
|
|
|
|
|
|
|
| RANI / Rani Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
| KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
| EVLO / Evelo Biosciences, Inc.
|
|
|
|
|
|
|
|
| DUOL / Duolingo, Inc.
|
|
|
|
|
|
|
|
| ME / 23andMe Holding Co.
|
|
|
|
|
|
|
|
| SNOW / Snowflake Inc.
|
|
|
|
|
|
|
|
| SANA / Sana Biotechnology, Inc.
|
|
|
|
|
|
|
|
| GTLB / GitLab Inc.
|
|
|
|
|
|
|
|
| AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TNYA / Tenaya Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| EQRX / EQRx Inc
|
|
|
|
|
|
|
|
| QNCX / Quince Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HYPR / Hyperfine, Inc.
|
|
|
|
|
|
|
|
| NVTAQ / Invitae Corporation
|
|
|
|
|
|
|
|
| ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
| SPRO / Spero Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LYEL / Lyell Immunopharma, Inc.
|
|
|
|
|
|
|
|
| PL / Planet Labs PBC
|
|
|
|
|
|
|
|
